Actinium Announces Collaboration With Albert Einstein College of Medicine on New Actinium Program

The first antibody to be labeled using the new technology has potential to be broadly used in the field of hematology/oncology. Preclinical studies of the new technology have demonstrated significant improvements in product's manufacturing while maintaining biological integrity and properties of labeled antibodies.

http://ift.tt/1zzl7NL